Literature DB >> 29159461

Severe Hyperammonemic Encephalopathy Requiring Dialysis Aggravated by Prolonged Fasting and Intermittent High Fat Load in a Ramadan Fasting Month in a Patient with CPTII Homozygous Mutation.

P Phowthongkum1,2, C Ittiwut3, V Shotelersuk4.   

Abstract

BACKGROUND: Carnitine palmitoyltransferase II (CPTII) deficiency is a mitochondrial fatty acid oxidation disorder that can present antenatally as congenital brain malformations, or postnatally with lethal neonatal, severe infantile, or the most common adult myopathic forms. No case of severe hyperammonemia without liver dysfunction has been reported. CASE
PRESENTATION: We described a 23-year-old man who presented to the emergency department with seizures and was found to have markedly elevation of serum ammonia. Continuous renal replacement therapy was initiated with successfully decreased ammonia to a safety level. He had a prolonged history of epilepsies and encephalopathic attacks that was associated with high ammonia level. Molecular diagnosis revealed a homozygous mutation in CPTII. The plasma acylcarnitine profile was consistent with the diagnosis. Failure to produce acetyl-CoA, the precursor of urea cycle from fatty acid in prolonged fasting state in Ramadan month, worsening mitochondrial functions from circulating long chain fatty acid and valproate toxicities were believed to contribute to this critical metabolic decompensation.
CONCLUSION: Fatty acid oxidation disorders should be considered in the differential diagnosis of hyperammonemia even without liver dysfunction. To our knowledge, this is the first case of CPTII deficiency presented with severe hyperammonemic encephalopathy required dialysis after prolonged religious related fasting.

Entities:  

Keywords:  CPTII deficiency; Carnitine palmitoyltransferase; Fatty acid oxidation disorder; Hyperammonemia; Long chain fatty acid; Rhabdomyolysis

Year:  2017        PMID: 29159461      PMCID: PMC6122042          DOI: 10.1007/8904_2017_74

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  25 in total

1.  Diagnostic pitfall in antenatal manifestations of CPT II deficiency.

Authors:  F Boemer; M Deberg; R Schoos; J-H Caberg; S Gaillez; C Dugauquier; K Delbecque; A François; P Maton; N Demonceau; G Senterre; S Ferdinandusse; F-G Debray
Journal:  Clin Genet       Date:  2015-05-05       Impact factor: 4.438

2.  Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency.

Authors:  Laure Thuillier; Hidayeth Rostane; Veronique Droin; France Demaugre; Michèle Brivet; Noman Kadhom; Carina Prip-Buus; Stéphanie Gobin; Jean-Marie Saudubray; Jean-Paul Bonnefont
Journal:  Hum Mutat       Date:  2003-05       Impact factor: 4.878

3.  Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency.

Authors:  Angelica Anichini; Marina Fanin; Christine Vianey-Saban; Denise Cassandrini; Chiara Fiorillo; Claudio Bruno; Corrado Angelini
Journal:  Neurol Res       Date:  2010-08-31       Impact factor: 2.448

4.  Organic acidaemia and Hyperammonaemia: review.

Authors:  M Walser; P M Stewart
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

5.  Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency.

Authors:  M Fanin; A Anichini; D Cassandrini; C Fiorillo; S Scapolan; C Minetti; M Cassanello; M A Donati; G Siciliano; A D'Amico; F Lilliu; C Bruno; C Angelini
Journal:  Clin Genet       Date:  2011-10-12       Impact factor: 4.438

6.  Fatty acid profiles of commercially available finfish fillets in the United States.

Authors:  Dennis P Cladis; Alison C Kleiner; Helene H Freiser; Charles R Santerre
Journal:  Lipids       Date:  2014-08-10       Impact factor: 1.880

Review 7.  Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.

Authors:  Jean-Paul Bonnefont; Fatima Djouadi; Carina Prip-Buus; Stephanie Gobin; Arnold Munnich; Jean Bastin
Journal:  Mol Aspects Med       Date:  2004 Oct-Dec

Review 8.  Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review.

Authors:  Ellen Sigauke; Dinesh Rakheja; Kimberly Kitson; Michael J Bennett
Journal:  Lab Invest       Date:  2003-11       Impact factor: 5.662

9.  Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency: functional analysis and association with polymorphic haplotypes and two clinical phenotypes.

Authors:  K Wataya; J Akanuma; P Cavadini; Y Aoki; S Kure; F Invernizzi; I Yoshida; J Kira; F Taroni; Y Matsubara; K Narisawa
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

10.  A surviving 24-month-old patient with neonatal-onset carnitine palmitoyltransferase II deficiency.

Authors:  Naohiro Ikeda; Shinsuke Maruyama; Kanna Nakano; Ryo Imakiire; Yumiko Ninomiya; Shunji Seki; Kosuke Yanagimoto; Yasuyuki Kakihana; Keiichi Hara; Go Tajima; Yasuhiro Okamoto; Yoshifumi Kawano
Journal:  Mol Genet Metab Rep       Date:  2017-05-09
View more
  2 in total

Review 1.  The Impact of Fasting on Major Metabolic Pathways of Macronutrients and Pharmacokinetics Steps of Drugs.

Authors:  Reza Karimi; Anita Cleven; Fawzy Elbarbry; Huy Hoang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

Review 2.  Update Review about Metabolic Myopathies.

Authors:  Josef Finsterer
Journal:  Life (Basel)       Date:  2020-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.